Subscribe
bee32
bee32 / iStockphoto.com
4 January 2018Americas

Native American tribe seeks information on PTAB judges

A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board (PTAB) judges overseeing inter partes reviews (IPRs) involving the tribe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

More on this story

Americas
Native American tribe hits back at Mylan in PTAB filing
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.
Americas
PTAB dismisses Native American tribe information request
8 January 2018   The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.
Big Pharma
Allergan tries to escape Restasis IPRs
10 January 2018   Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?